Perioperative Fluoroquinolone Treatment Deteriorates Prognosis Following Coronary Artery Bypass Grafting

Background: Former studies have revealed that fluoroquinolone (FQ) can induce aortic expansion and rupture. While FQ is widely used in perioperative anti-infection therapy, its impact on graft patency and patient survival is unknown. Methods: Coronary artery bypass grafting (CABG) data were extracte...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Min, Jian, Lijuan, Min, Xinping, Li, Bowen, Cai, Xin, Wang, Zhiwei, Hu, Zhipeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224777/
https://www.ncbi.nlm.nih.gov/pubmed/35735802
http://dx.doi.org/10.3390/jcdd9060173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224777/
https://www.ncbi.nlm.nih.gov/pubmed/35735802
http://dx.doi.org/10.3390/jcdd9060173

Ejemplares similares